Longevity Health Stock (NASDAQ:XAGE)
Previous Close
$0.39
52W Range
$0.37 - $36.00
50D Avg
$0.55
200D Avg
$2.84
Market Cap
$623.17K
Avg Vol (3M)
$8.94K
Beta
0.33
Div Yield
-
XAGE Company Profile
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.